FDA OK's Generic Versions of Antidepressant Cymbalta
WebMD News Archive
The first generic versions of the antidepressant Cymbalta have been approved by the U.S. Food and Drug Administration.
The agency okayed six generic versions of the drug from a number of companies, including Teva Pharmaceuticals, Sun Pharma Global and Dr. Reddy's Laboratories Ltd., the Associated Press reported.
Cymbalta, the fifth best selling medication in the world in 2012, is marketed by Eli Lilly & Co. Inc. The company's patent on Cymbalta expired Wednesday. Generic drugs typically sell for much less than the original branded product.
Along with depression, Cymbalta is also used to treat generalized anxiety disorder, fibromyalgia, diabetic nerve pain, and some types of chronic pain, the AP reported.